Dong Ho Lee

ImpriMed, founded in 2017 in Silicon Valley, is a leading precision medicine startup revolutionizing cancer treatment with artificial intelligence. The company’s pioneering drug response prediction technology helps reduce costs, accelerate treatment, enhance efficacy, and improve the quality of life for patients. To date, the company’s technology has been deployed across more than 40 U.S. states, and 22,000+ canine and feline blood cancer tests have been performed as of 2025. ImpriMed is now poised to extend its groundbreaking AI-driven approach to human healthcare, redefining the future of oncology treatment with personalized, effective solutions. For additional information, visit www.imprimedicine.com.

CerebrumX Labs Inc. (www.cerebrumx.ai) is a game changer in automotive data technology that leverages Generative AI to Enhance Data-Driven Insights for connected vehicles. Our industry’s first AI-Powered Augmented Deep Learning Platform (ADLP) is uniquely positioned to effectively utilize advanced analytics and AI for real-time data processing, thereby facilitating automotive ecosystem. By harnessing generative AI and Machine Learning algorithms we are redefining data to pre-build models that boost automation and minimize human interaction, for unparalleled innovation, operational optimization, and informed decisions. ADLP securely collects and consolidates scattered data from partners and third-party apps and devices, empowering businesses across the edge and core network to our partners including Fleets, Auto Insurers, Automotive Aftermarket, Dealerships and EVs. With generative AI, insurers can make faster and more informed decisions, leading to better risk assessments, more accurate underwriting, and streamlined claims processing. CerebrumX is headquartered in Detroit, Michigan, with offices across NA, EMEA and APAC, and has partnered with top 4 OEMs in North America. Explore more at: www.cerebrumx.ai

Nanox AI is lighting up new pathways for smart population healthcare management with AI-based solutions, identifying patients at risk of having chronic disease and enabling the start of preventative care pathways. Integrated delivery networks and payers benefit from this technology with more accurate risk-adjustment, timely intervention, and improved quality of health services, while significantly reducing the associated costs. Nanox AI enables better, fairly reimbursed population health management and wellbeing for larger patient populations. #population health #AI #machine learning #digitalhealth #medicalimaging

Aurora Labs is pioneering the use of AI and Software Intelligence to solve the challenge of automotive software development. Aurora Labs brings AI-based Vehicle Software Intelligence to the entire lifecycle of a vehicle from software development to testing, integration, quality control, continuous certification and on-the-road over-the-air software updates. Aurora Labs focuses on the embedded systems that are key to the development of the software-defined vehicle and enables automotive manufacturers to more efficiently manage software costs and the resources required to develop and manage new vehicle features and mobility services. Aurora Labs’ products have been adopted on customer platforms around the world, and with a commitment to conform and meet ISO-26262/ASIL-D and ASPICE-L2, will be in vehicles in coming car models. Aurora Labs, founded in 2016, has raised approximately $100m and has been granted 90 patents. Aurora Labs is headquartered in Tel Aviv, Israel, with offices in Germany, North Macedonia, the US, and Japan.

We aim to make transit more sustainable, safe, accessible and equitable for everyone by building a better autonomous vehicle technology that works in the real world. Weve delivered shared, on-demand rides to communities at ten sites across the U.S. and Japan.

Moving the world better – that’s the backbone of everything we do. At Ridecell, we pride ourselves on helping the largest fleets in the world digitally transform their business operations to achieve their goals, no matter how big or adventurous. Our fleet automation and mobility platform modernizes and monetizes fleets by combining real-time data insights with digital vehicle control that turns manual processes into automated workflows. Imagining a world where fleets fix and run themselves is no longer a concept – it’s a reality. The results? Unmatched efficiency, unparalleled control, and complete transparency for shared services, motorpool, rental and logistic fleets who rely on vehicles and drivers to move their business forward. Today, Ridecell powers some of the most successful fleets across Europe and North America including Gig Car Share from AAA, Arval and KINTO Share by Toyota Sweden. Headquartered in San Francisco, California, with offices in Madrid, Paris, Berlin and Pune, India, Ridecell builds the technologies and solutions that unlock the full power of fleets. To learn more about our suite of solutions, visit https://ridecell.com/.

The Superintelligence Cloud

Moloco’s mission is to be the scaling engine for the internet economy, applying AI to help businesses of all sizes grow. With Moloco’s artificial intelligence platform for growth and performance, every app publisher, commerce marketplace, and streaming business can now unlock the value of their unique, first-party data. Moloco Ads enables performance marketers to scale user acquisition for mobile apps through our advanced artificial intelligence. Moloco Commerce Media enables retailers and marketplaces to build their own ads business with a flexible solution that delivers relevance, results, and automation for scaled and streamlined ad operations. Moloco Streaming Monetization enables streaming media companies to revolutionize their monetization strategy by building an outcomes-based ads business that delivers relevancy for users and results for advertisers. Moloco was founded in 2013 by a team of machine learning engineers and has offices throughout the US, the UK, Germany, Korea, China, India, Japan, and Singapore.

ImpriMed, founded in 2017 in Silicon Valley, is a leading precision medicine startup revolutionizing cancer treatment with artificial intelligence. The company’s pioneering drug response prediction technology helps reduce costs, accelerate treatment, enhance efficacy, and improve the quality of life for patients. To date, the company’s technology has been deployed across more than 40 U.S. states, and 22,000+ canine and feline blood cancer tests have been performed as of 2025. ImpriMed is now poised to extend its groundbreaking AI-driven approach to human healthcare, redefining the future of oncology treatment with personalized, effective solutions. For additional information, visit www.imprimedicine.com.

CerebrumX Labs Inc. (www.cerebrumx.ai) is a game changer in automotive data technology that leverages Generative AI to Enhance Data-Driven Insights for connected vehicles. Our industry’s first AI-Powered Augmented Deep Learning Platform (ADLP) is uniquely positioned to effectively utilize advanced analytics and AI for real-time data processing, thereby facilitating automotive ecosystem. By harnessing generative AI and Machine Learning algorithms we are redefining data to pre-build models that boost automation and minimize human interaction, for unparalleled innovation, operational optimization, and informed decisions. ADLP securely collects and consolidates scattered data from partners and third-party apps and devices, empowering businesses across the edge and core network to our partners including Fleets, Auto Insurers, Automotive Aftermarket, Dealerships and EVs. With generative AI, insurers can make faster and more informed decisions, leading to better risk assessments, more accurate underwriting, and streamlined claims processing. CerebrumX is headquartered in Detroit, Michigan, with offices across NA, EMEA and APAC, and has partnered with top 4 OEMs in North America. Explore more at: www.cerebrumx.ai

Nanox AI is lighting up new pathways for smart population healthcare management with AI-based solutions, identifying patients at risk of having chronic disease and enabling the start of preventative care pathways. Integrated delivery networks and payers benefit from this technology with more accurate risk-adjustment, timely intervention, and improved quality of health services, while significantly reducing the associated costs. Nanox AI enables better, fairly reimbursed population health management and wellbeing for larger patient populations. #population health #AI #machine learning #digitalhealth #medicalimaging